530 related articles for article (PubMed ID: 7577804)
1. Both CD28 ligands CD80 (B7-1) and CD86 (B7-2) activate phosphatidylinositol 3-kinase, and wortmannin reveals heterogeneity in the regulation of T cell IL-2 secretion.
Ueda Y; Levine BL; Huang ML; Freeman GJ; Nadler LM; June CH; Ward SG
Int Immunol; 1995 Jun; 7(6):957-66. PubMed ID: 7577804
[TBL] [Abstract][Full Text] [Related]
2. CD28 co-stimulatory regimes differ in their dependence on phosphatidylinositol 3-kinase: common co-signals induced by CD80 and CD86.
Cefai D; Cai YC; Hu H; Rudd C
Int Immunol; 1996 Oct; 8(10):1609-16. PubMed ID: 8921441
[TBL] [Abstract][Full Text] [Related]
3. CD28 ligands CD80 (B7-1) and CD86 (B7-2) induce long-term autocrine growth of CD4+ T cells and induce similar patterns of cytokine secretion in vitro.
Levine BL; Ueda Y; Craighead N; Huang ML; June CH
Int Immunol; 1995 Jun; 7(6):891-904. PubMed ID: 7577797
[TBL] [Abstract][Full Text] [Related]
4. CD80 and CD86 are not equivalent in their ability to induce the tyrosine phosphorylation of CD28.
Slavik JM; Hutchcroft JE; Bierer BE
J Biol Chem; 1999 Jan; 274(5):3116-24. PubMed ID: 9915850
[TBL] [Abstract][Full Text] [Related]
5. Human neutrophil-expressed CD28 interacts with macrophage B7 to induce phosphatidylinositol 3-kinase-dependent IFN-gamma secretion and restriction of Leishmania growth.
Venuprasad K; Banerjee PP; Chattopadhyay S; Sharma S; Pal S; Parab PB; Mitra D; Saha B
J Immunol; 2002 Jul; 169(2):920-8. PubMed ID: 12097397
[TBL] [Abstract][Full Text] [Related]
6. Disparate effects of phorbol esters, CD3 and the costimulatory receptors CD2 and CD28 on RANTES secretion by human T lymphocytes.
Sotsios Y; Blair PJ; Westwick J; Ward SG
Immunology; 2000 Sep; 101(1):30-7. PubMed ID: 11012750
[TBL] [Abstract][Full Text] [Related]
7. Phosphatidylinositol 3-kinase activity is not essential for CD28 costimulatory activity in Jurkat T cells: studies with a selective inhibitor, wortmannin.
Lu Y; Phillips CA; Trevillyan JM
Eur J Immunol; 1995 Feb; 25(2):533-7. PubMed ID: 7875216
[TBL] [Abstract][Full Text] [Related]
8. Selective CD28pYMNM mutations implicate phosphatidylinositol 3-kinase in CD86-CD28-mediated costimulation.
Cai YC; Cefai D; Schneider H; Raab M; Nabavi N; Rudd CE
Immunity; 1995 Oct; 3(4):417-26. PubMed ID: 7584133
[TBL] [Abstract][Full Text] [Related]
9. Phorbol ester treatment inhibits phosphatidylinositol 3-kinase activation by, and association with, CD28, a T-lymphocyte surface receptor.
Hutchcroft JE; Franklin DP; Tsai B; Harrison-Findik D; Varticovski L; Bierer BE
Proc Natl Acad Sci U S A; 1995 Sep; 92(19):8808-12. PubMed ID: 7568022
[TBL] [Abstract][Full Text] [Related]
10. Ligation of CD28 receptor by B7 induces formation of D-3 phosphoinositides in T lymphocytes independently of T cell receptor/CD3 activation.
Ward SG; Westwick J; Hall ND; Sansom DM
Eur J Immunol; 1993 Oct; 23(10):2572-7. PubMed ID: 8405057
[TBL] [Abstract][Full Text] [Related]
11. Comparison of CD28-B7.1 and B7.2 functional interaction in resting human T cells: phosphatidylinositol 3-kinase association to CD28 and cytokine production.
Ghiotto-Ragueneau M; Battifora M; Truneh A; Waterfield MD; Olive D
Eur J Immunol; 1996 Jan; 26(1):34-41. PubMed ID: 8566081
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of CD28-mediated T cell costimulation by the phosphoinositide 3-kinase inhibitor wortmannin.
Ward SG; Wilson A; Turner L; Westwick J; Sansom DM
Eur J Immunol; 1995 Feb; 25(2):526-32. PubMed ID: 7875215
[TBL] [Abstract][Full Text] [Related]
13. CD28-mediated costimulation in the absence of phosphatidylinositol 3-kinase association and activation.
Crooks ME; Littman DR; Carter RH; Fearon DT; Weiss A; Stein PH
Mol Cell Biol; 1995 Dec; 15(12):6820-8. PubMed ID: 8524248
[TBL] [Abstract][Full Text] [Related]
14. Costimulation light: activation of CD4+ T cells with CD80 or CD86 rather than anti-CD28 leads to a Th2 cytokine profile.
Broeren CP; Gray GS; Carreno BM; June CH
J Immunol; 2000 Dec; 165(12):6908-14. PubMed ID: 11120816
[TBL] [Abstract][Full Text] [Related]
15. Effect of CD80 and CD86 on T cell cytokine production.
Petro TM; Chen SS; Panther RB
Immunol Invest; 1995 Nov; 24(6):965-76. PubMed ID: 8575841
[TBL] [Abstract][Full Text] [Related]
16. Differential down-regulation of CD28 by B7-1 and B7-2 engagement.
Eck SC; Chang D; Wells AD; Turka LA
Transplantation; 1997 Nov; 64(10):1497-9. PubMed ID: 9392322
[TBL] [Abstract][Full Text] [Related]
17. Differential requirements for co-stimulatory signals from B7 family members by resting versus recently activated memory T cells towards soluble recall antigens.
Yi-qun Z; Joost van Neerven RJ; Kasran A; de Boer M; Ceuppens JL
Int Immunol; 1996 Jan; 8(1):37-44. PubMed ID: 8671587
[TBL] [Abstract][Full Text] [Related]
18. B7-2 (CD86) is essential for the development of IL-4-producing T cells.
Ranger AM; Das MP; Kuchroo VK; Glimcher LH
Int Immunol; 1996 Oct; 8(10):1549-60. PubMed ID: 8921434
[TBL] [Abstract][Full Text] [Related]
19. Phorbol esters modulate the coupling of the T cell costimulatory molecule CD28 to phosphatidylinositol 3-kinase.
Parry RV; Boulougouris G; Sansom DM; Ward SG
Biochem Soc Trans; 1997 May; 25(2):305S. PubMed ID: 9191349
[No Abstract] [Full Text] [Related]
20. Ligation of the V7 molecule on T cells blocks anergy induction through a CD28-independent mechanism.
Soares LR; Rivas A; Tsavaler L; Engleman EG
J Immunol; 1997 Aug; 159(3):1115-24. PubMed ID: 9233604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
